Critical issues of the regulatory pathway for nanostructured medical devices
The increasing diffusion of nanomaterials (NM) is having a remarkable impact in the domain of medical devices (MD). Hence, nanostructured MDs are becoming common, even though the associated risks must be carefully considered in order to demonstrate safety. The biological effects of NMs require the c...
Gespeichert in:
Veröffentlicht in: | AIP conference proceedings 2021-11, Vol.2416 (1) |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!